Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1¿ signaling pathway Jing Yang; Suxin Li; Shengyan Liu; Yuehui Zhang; Dongqi Shen; Peiju Wang; Xiaowei Dang;

Assessment of metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease, and metabolic dysfunction and alcohol-associated steatotic liver disease in open Mexican population Jorge Emilio Lira-Vera; Ángel Daniel Santana-Vargas; Gabriela Gutiérrez-Reyes; Oscar Morales-Gutiérrez; María de Fátima Higuera-de la Tijera; Diana Montemira-Orozco; Christian Hinojosa-Segura; Moisés Martínez-Castillo; Samantha Sánchez-Valle; María de los Ángeles Lemus-Peña; Daniel Montes de Oca-Ángeles; Abigail Hernández-Barragán; Marisela Hernández-Santillán; Yadira Lilian Béjar-Ramírez; José Luis Pérez-Hernández;

Aspartate aminotransferase¿to¿platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitis Martine A.M.C. Baven-Pronk; Camiel J.M. Marijnissen; Maaike Biewenga; Albert F. Stättermayer; Maarten E. Tushuizen; Bart van Hoek;